MOBILion Systems, a Life Sciences company, announced the close of a $60 million Series C financing round. The round was led by D1 Capital Partners with the remaining funds contributed by existing investors aMoon, Agilent Technologies (NYSE:A), IP Group, Hostplus and Cultivation Capital.

MOBILion Systems delivers high-resolution, high-throughput analysis for the pharmaceutical industry and clinical researchers to enable earlier disease detection, improve diagnostic accuracy and to accelerate drug development with deeper, faster characterization of more complex biologic therapeutics.